Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma
0301 basic medicine
Brain Neoplasms
Cell Survival
Glioma
Survival Analysis
Article
Dacarbazine
03 medical and health sciences
Drug Resistance, Neoplasm
Cell Line, Tumor
Gene Knockdown Techniques
Temozolomide
Humans
Protein Interaction Maps
Signal Transduction
DOI:
10.1038/srep16830
Publication Date:
2015-11-19T10:10:19Z
AUTHORS (2)
ABSTRACT
AbstractBiological networks display high robustness against random failures but are vulnerable to targeted attacks on central nodes. Thus, network topology analysis represents a powerful tool for investigating network susceptibility against targeted node removal. Here, we built protein interaction networks associated with chemoresistance to temozolomide, an alkylating agent used in glioma therapy and analyzed their modular structure and robustness against intentional attack. These networks showed functional modules related to DNA repair, immunity, apoptosis, cell stress, proliferation and migration. Subsequently, network vulnerability was assessed by means of centrality-based attacks based on the removal of node fractions in descending orders of degree, betweenness, or the product of degree and betweenness. This analysis revealed that removing nodes with high degree and high betweenness was more effective in altering networks’ robustness parameters, suggesting that their corresponding proteins may be particularly relevant to target temozolomide resistance. In silico data was used for validation and confirmed that central nodes are more relevant for altering proliferation rates in temozolomide-resistant glioma cell lines and for predicting survival in glioma patients. Altogether, these results demonstrate how the analysis of network vulnerability to topological attack facilitates target prioritization for overcoming cancer chemoresistance.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (66)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....